gyki 52466 has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapus, G | 1 |
| Székely, JI | 1 |
| Durand, J | 1 |
| Ruiz, A | 1 |
| Tarnawa, I | 1 |
1 other study available for gyki 52466 and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Epilepsy; Excitator | 2000 |